AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $223,304 | -94.7% | 21,680 | -91.6% | 0.00% | -100.0% |
Q2 2023 | $4,252,664 | +1692.6% | 258,050 | +896.4% | 0.00% | – |
Q1 2023 | $237,235 | -55.8% | 25,899 | -65.4% | 0.00% | – |
Q4 2022 | $536,277 | +562.1% | 74,899 | +125.5% | 0.00% | – |
Q2 2022 | $81,000 | -72.3% | 33,220 | -22.4% | 0.00% | – |
Q1 2022 | $292,000 | -78.3% | 42,804 | -74.3% | 0.00% | – |
Q4 2021 | $1,348,000 | +164.3% | 166,869 | +220.9% | 0.00% | – |
Q3 2021 | $510,000 | +335.9% | 52,000 | +198.9% | 0.00% | – |
Q2 2021 | $117,000 | -89.3% | 17,397 | -85.6% | 0.00% | – |
Q1 2021 | $1,094,000 | +835.0% | 121,005 | +589.7% | 0.00% | – |
Q4 2020 | $117,000 | +23.2% | 17,545 | +50.0% | 0.00% | – |
Q2 2020 | $95,000 | +66.7% | 11,700 | -15.3% | 0.00% | – |
Q3 2019 | $57,000 | – | 13,819 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 520,830 | $2,625,000 | 1.69% |
COWEN AND COMPANY, LLC | 1,905,990 | $9,606,000 | 1.57% |
Ghost Tree Capital, LLC | 825,000 | $4,158,000 | 1.20% |
GENDELL JEFFREY L | 1,115,211 | $5,621,000 | 1.18% |
Vivo Capital, LLC | 3,526,093 | $17,772,000 | 1.03% |
ACUTA CAPITAL PARTNERS, LLC | 705,218 | $3,554,000 | 0.96% |
RTW INVESTMENTS, LP | 5,366,705 | $27,048,000 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 2,840,669 | $14,317,000 | 0.50% |
Avoro Capital Advisors LLC | 4,200,000 | $21,168,000 | 0.30% |
HighVista Strategies LLC | 57,495 | $290,000 | 0.21% |